Rasagiline (Chongqing Pharmaceutical Research Institute)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRasagiline (Chongqing Pharmaceutical Research Institute)
Drug Alias Namerasagiline
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitors
TargetsMonoamine oxidase B
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesChongqing Pharmaceutical Research Institute Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChongqing Pharmaceutical Research Institute Co Ltd
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A